The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
The QT interval
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults
Calle, E. E., Thun, M. J., Petrelli, J. M., Rodriguez, C., & Heath, C. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910073411501 · Cited by 3,643
Body Weight and Mortality among Women
Manson, J. E., Willett, W. C., Stampfer, M. J., Colditz, G. A., Hunter, D. J., Hankinson, S. E., Hennekens, C. H., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509143331101 · Cited by 1,988
Jervell, A., & Lange-Nielsen, F. (1957) · American Heart Journal · doi:10.1016/0002-8703(57)90079-0 · Cited by 1,596
QT dispersion: an indication of arrhythmia risk in patients with long QT intervals.
Day, C. P., McComb, J. M., & Campbell, R. W. (1990) · Heart · doi:10.1136/hrt.63.6.342 · Cited by 1,189
Clinical Cardiac Electrophysiology: Techniques and Interpretations.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-6-880_2 · Cited by 1,051
Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken
FRIDERICIA, L. S. (1920) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1920.tb18266.x · Cited by 1,000
Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular Drugs
Makkar, R. R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510210076031 · Cited by 971
Body Mass Index and Mortality in a Prospective Cohort of US Adults
Calle, E. E., Thun, M. J., Petrelli, J. M., Rodriguez, C., & Heath, C. W. (2000) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200003000-00010 · Cited by 918
Low Penetrance in the Long-QT Syndrome: Clinical Impact
Priori, S. G., Napolitano, C., & Schwartz, P. J. (1999) · Circulation · doi:10.1161/01.cir.99.4.529 · Cited by 804
QT dispersion and sudden unexpected death in chronic heart failure
Barr, C. S., Naas, A., Freeman, M., Lang, C. C., & Struthers, A. D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91164-9 · Cited by 769
QT interval prolongation as predictor of sudden death in patients with myocardial infarction.
Schwartz, P. J., & Wolf, S. (1978) · Circulation · doi:10.1161/01.cir.57.6.1074 · Cited by 753
Tran, P. V., Hamilton, S. H., Kuntz, A. J., Potvin, J. H., Andersen, S. W., Beasley, C. J., & Tollefson, G. D. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199710000-00010 · Cited by 715
An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)
Sagie, A., Larson, M. G., Goldberg, R. J., Bengtson, J. R., & Levy, D. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90562-d · Cited by 715
Schwartz, P. J. (1997) · Current Problems in Cardiology · doi:10.1016/s0146-2806(97)80009-6 · Cited by 693
Long QT syndromes and torsade de pointes
Viskin, S. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02107-8 · Cited by 689
Torsades de Pointes Occurring in Association With Terfenadine Use
Monahan, B. P. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450210088038 · Cited by 667
Terfenadine-Ketoconazole Interaction: Pharmacokinetic and Electrocardiographic Consequences
Honig, P. K. (1993) · JAMA · doi:10.1001/jama.1993.03500120051025 · Cited by 664
A Single Na + Channel Mutation Causing Both Long-QT and Brugada Syndromes
Bezzina, C., Veldkamp, M. W., van den Berg, M. P., Postma, A. V., Rook, M. B., Viersma, J.-W., van Langen, I. M., Tan-Sindhunata, G., Bink-Boelkens, M. T. E., van der Hout, A. H., et al. (1999) · Circulation Research · doi:10.1161/01.res.85.12.1206 · Cited by 656
Mechanism of the Cardiotoxic Actions of Terfenadine
Woosley, R. L. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500120070028 · Cited by 646
QT interval prolongation predicts cardiovascular mortality in an apparently healthy population.
Schouten, E. G., Dekker, J. M., Meppelink, P., Kok, F. J., Vandenbroucke, J. P., & Pool, J. (1991) · Circulation · doi:10.1161/01.cir.84.4.1516 · Cited by 630
Multiple Mechanisms in the Long-QT Syndrome: Current Knowledge, Gaps, and Future Directions
Roden, D. M., Lazzara, R., Rosen, M., Schwartz, P. J., Towbin, J., & Vincent, G. M. (1996) · Circulation · doi:10.1161/01.cir.94.8.1996 · Cited by 628
Berger, R. D., Kasper, E. K., Baughman, K. L., Marban, E., Calkins, H., & Tomaselli, G. F. (1997) · Circulation · doi:10.1161/01.cir.96.5.1557 · Cited by 614
Algra, A., Tijssen, J. G., Roelandt, J. R., Pool, J., & Lubsen, J. (1991) · Circulation · doi:10.1161/01.cir.83.6.1888 · Cited by 592
The Diagnostic Performance of Computer Programs for the Interpretation of Electrocardiograms
Willems, J. L., Abreu-Lima, C., Arnaud, P., van Bemmel, J. H., Brohet, C., Degani, R., Denis, B., Gehring, J., Graham, I., van Herpen, G., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112193252503 · Cited by 539
Eckel, R. H. (1997) · Circulation · doi:10.1161/01.cir.96.9.3248 · Cited by 513
Roden, D. M., Woosley, R. L., & Primm, R. K. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90010-4 · Cited by 488
Measurement of the QT interval and the risk associated with QTc interval prolongation: A review
Moss, A. J. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90036-c · Cited by 472
Neal Kay, G., Vance J., P., Joaquin G., A., Richard W., H., & Albert L., W. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80226-5 · Cited by 463
Sex Difference in Risk of Torsade de Pointes With d,l- Sotalol
Lehmann, M. H., Hardy, S., Archibald, D., Quart, B., & MacNeil, D. J. (1996) · Circulation · doi:10.1161/01.cir.94.10.2535 · Cited by 458
Franz, M. R., Swerdlow, C. D., Liem, L. B., & Schaefer, J. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113706 · Cited by 457
Linking a genetic defect to its cellular phenotype in a cardiac arrhythmia
Clancy, C. E., & Rudy, Y. (1999) · Nature · doi:10.1038/23034 · Cited by 442
Rate-corrected QT interval: Techniques and limitations
Funck-Brentano, C., & Jaillon, P. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90035-b · Cited by 401
Drouin, E., Charpentier, F., Gauthier, C., Laurent, K., & Le Marec, H. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00167-x · Cited by 388
Buja, G., Miorelli, M., Turrini, P., Melacini, P., & Nava, A. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)91118-2 · Cited by 381
Honig, P. K., Woosley, R. L., Zamani, K., Conner, D. P., & Cantilena, L. R. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.135 · Cited by 367
Shapiro, E. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810080052006 · Cited by 355
Zabel, M., Klingenheben, T., Franz, M. R., & Hohnloser, S. H. (1998) · Circulation · doi:10.1161/01.cir.97.25.2543 · Cited by 321
Elming, H. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1094 · Cited by 320
Subclinical Disease as an Independent Risk Factor for Cardiovascular Disease
Kuller, L. H., Shemanski, L., Psaty, B. M., Borhani, N. O., Gardin, J., Haan, M. N., O’Leary, D. H., Savage, P. J., Tell, G. S., & Tracy, R. (1995) · Circulation · doi:10.1161/01.cir.92.4.720 · Cited by 313
Diurnal pattern of QTc interval: How long is prolonged?
Molnar, J., Zhang, F., Weiss, J., Ehlert, F. A., & Rosenthal, J. E. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00426-2 · Cited by 312
Cellular and Ionic Basis for T-Wave Alternans Under Long-QT Conditions
Shimizu, W., & Antzelevitch, C. (1999) · Circulation · doi:10.1161/01.cir.99.11.1499 · Cited by 301
Prolonged QT interval predicts cardiac and all-cause mortality in the elderly The Rotterdam Study
de Bruyne, M. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1276 · Cited by 298
Cardiovascular Effects of Therapeutic Doses of Tricyclic Antidepressants in Children and Adolescents
WILENS, T. E., BIEDERMAN, J., BALDESSARINI, R. J., GELLER, B., SCHLEIFER, D., SPENCER, T. J., BIRMAHER, B., & GOLDBLATT, A. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199611000-00018 · Cited by 296
Genetic and Molecular Basis of Cardiac Arrhythmias: Impact on Clinical Management Parts I and II
Priori, S. G., Barhanin, J., Hauer, R. N. W., Haverkamp, W., Jongsma, H. J., Kleber, A. G., McKenna, W. J., Roden, D. M., Rudy, Y., Schwartz, K., et al. (1999) · Circulation · doi:10.1161/01.cir.99.4.518 · Cited by 294
Dekker, J. M., Schouten, E. G., Klootwijk, P., Pool, J., & Kromhout, D. (1994) · Circulation · doi:10.1161/01.cir.90.2.779 · Cited by 275
Karjalainen, J., Viitasalo, M., Mänttäri, M., & Manninen, V. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90654-8 · Cited by 264
QT prolongation and sudden cardiac death in patients with alcoholic liver disease
Campbell, R. W. F., Day, C. P., James, O. F. W., & Butler, T. J. (1993) · The Lancet · doi:10.1016/0140-6736(93)90879-l · Cited by 254
Short‐and Long‐Term Reproducibility of QT, QTc, and QT Dispersion Measurement in Healthy Subjects
KAUTZNER, J., YI, G., CAMM, A. J., & MALIK, M. (1994) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1994.tb01435.x · Cited by 250
Self-citationDiurnal variation of the QT interval--influence of the autonomic nervous system.
Bexton, R. S., Vallin, H. O., & Camm, A. J. (1986) · Heart · doi:10.1136/hrt.55.3.253 · Cited by 240
Self-citationCellular basis for QT dispersion
Antzelevitch, C., Shimizu, W., Yan, G.-X., & Sicouri, S. (1998) · Journal of Electrocardiology · doi:10.1016/s0022-0736(98)80070-8 · Cited by 240
The Safety of Newly Approved Medicines: Do Recent Market Removals Mean There Is a Problem?
Friedman, M. A., Woodcock, J., Lumpkin, M. M., Shuren, J. E., Hass, A. E., & Thompson, L. J. (1999) · JAMA · doi:10.1001/jama.281.18.1728 · Cited by 238
CARDIOVASCULAR EFFECTS OF OBESITY AND HYPERTENSION
Messerli, F. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92234-6 · Cited by 236
Long QT: Good, bad or indifferent?
Surawicz, B., & Knoebel, S. B. (1984) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(84)80232-6 · Cited by 232
Torsades de Pointes Associated With Intravenous Haloperidol in Critically Ill Patients
Sharma, N. D., Rosman, H. S., Padhi, I. D., & Tisdale, J. E. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00888-6 · Cited by 232
Goldberg, R. J., Bengtson, J., Chen, Z., Anderson, K. M., Locati, E., & Levy, D. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90099-7 · Cited by 231
Isner, J. M., Sours, H. E., Paris, A. L., Ferrans, V. J., & Roberts, W. C. (1979) · Circulation · doi:10.1161/01.cir.60.6.1401 · Cited by 228
Prolongation of the Q-T interval in man during sleep
Browne, K. F., Prystowsky, E., Heger, J. J., Chilson, D. A., & Zipes, D. P. (1983) · The American Journal of Cardiology · doi:10.1016/0002-9149(83)90068-1 · Cited by 215
QT Interval Prolongation and Sudden Cardiac Death in Diabetic Autonomic Neuropathy*
KAHN, J. K., SISSON, J. C., & VINIK, A. I. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-4-751 · Cited by 209
How to measure the QT interval—What is normal?
Garson, A. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90034-a · Cited by 204
Bazett's QT correction reviewed : Evidence that a linear QT correction for heart rate is better
Hodges, M. (1983) · Journal of the American College of Cardiology · Cited by 195
(1963) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1963.03710030141099 · Cited by 187
Morganroth, J., Brozovich, F. V., McDonald, J. T., & Jacobs, R. A. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90541-r · Cited by 183
Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death?
Bellavere, F., Ferri, M., Guarini, L., Bax, G., Piccoli, A., Cardone, C., & Fedele, D. (1988) · Heart · doi:10.1136/hrt.59.3.379 · Cited by 182
Benton, R. E., Honig, P. K., Zamani, K., Cantilena, L. R., & Woosley, R. L. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90105-8 · Cited by 181
QT interval variables from 24 hour electrocardiography and the two year risk of sudden death.
Algra, A., Tijssen, J. G., Roelandt, J. R., Pool, J., & Lubsen, J. (1993) · Heart · doi:10.1136/hrt.70.1.43 · Cited by 179
The electrocardiogram in obesity: Statistical analysis of 1,029 patients
Frank, S., Colliver, J. A., & Frank, A. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80494-6 · Cited by 173
Veglio, M., Borra, M., Stevens, L. K., Fuller, J. H., & Perin, P. C. (1999) · Diabetologia · doi:10.1007/s001250051115 · Cited by 167
Prolonged QT-Interval Syndromes
Moss, A. J. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03380210081029 · Cited by 158
Torsade de pointes after astemizole overdose.
Craft, T. M. (1986) · BMJ · doi:10.1136/bmj.292.6521.660 · Cited by 156
Relationship between the pharmacokinetics and pharmacodynamics of procainamide
Galeazzi, R. L., Benet, L. Z., & Sheiner, L. B. (1976) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1976203278 · Cited by 153
Naas, A. A. O., Davidson, N. C., Thompson, C. S. G., Cummings, F. J. R., Ogston, S., Jung, R. T., Newton, R. W., & Struthers, A. D. (1998) · BMJ · doi:10.1136/bmj.316.7133.745 · Cited by 150
Cardiotoxicity More Common in Thioridazine Overdose than with Other Neuroleptics
Buckley, N. A., Whyte, I. M., & Dawson, A. H. (1995) · Journal of Toxicology Clinical Toxicology · doi:10.3109/15563659509017984 · Cited by 148
The influence of cisapride and clarithromycin on QT intervals in healthy volunteers
van Haarst, A. D., Klooster, G. A. E. V. '., van Gerven, J., Schoemaker, R. C., van Oene, J. C., Burggraaf, J., Coene, M. C., & Cohen, A. F. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90137-0 · Cited by 147
Pratt, C. M., Ruberg, S. J., Morganroth, J., McNutt, B. E., Woodward, J. K., Harris, S. I., Ruskin, J. N., & Moyé, L. A. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90525-6 · Cited by 143
Self-citation(1983) · Circulation · doi:10.1161/01.cir.67.5.1117 · Cited by 143
Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus
Landstedt‐Hallin, L., Englund, A., Adamson, U., & Lins, P. ‐. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00528.x · Cited by 141
Proarrhythmia With Class III Antiarrhythmic Drugs: Types, Risks, and Management
Hohnloser, S. H. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00717-0 · Cited by 140
The normal duration of the Q-T interval
ASHMAN, R. B. (1942) · American Heart Journal · doi:10.1016/s0002-8703(42)90297-7 · Cited by 136
Effects of obesity on QT, RR, and QTc intervals
El-Gamal, A. E. M., Gallagher, D., Nawras, A. T., Gandhi, P., Gómez, J. M., Allison, D. B., Steinberg, J. S., Shumacher, D., Blank, R. C., & Heymsfield, S. B. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80700-0 · Cited by 130
Desta, Z., Kerbusch, T., & Flockhart, D. A. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70117-7 · Cited by 129
ASTEMIZOLE-INDUCED TORSADE DE POINTES
Simons, F. E. R., Kesselman, M., Giddins, N. G., et al. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90656-3 · Cited by 126
QT interval as a cardiac risk factor in a middle aged population.
Karjalainen, J., Reunanen, A., Ristola, P., & Viitasalo, M. T. (1997) · Heart · doi:10.1136/hrt.77.6.543 · Cited by 126
Torsade de Pointes Associated with the Use of Intravenous Haloperidol
Wilt, J. L., Minnema, A. M., Johnson, R. F., & Rosenblum, A. M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-5-199309010-00007 · Cited by 126
Metzger, E., & Friedman, R. A. (1993) · PubMed · Cited by 126
Pohjola‐Sintonen, S., Viitasalo, M. T., Toivonen, L., & Neuvonen, P. J. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315505 · Cited by 118
ECG changes during haloperidol and pimozide treatment of Tourette's disorder
Fulop, G., Phillips, R. A., Shapiro, A. K., Gomes, J. A., Shapiro, E., & Nordlie, J. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.5.673 · Cited by 117
Ahnve, S., Gilpin, E. A., Madsen, E. B., Froelicher, V. F., Henning, H., & Ross, J. (1984) · American Heart Journal · doi:10.1016/0002-8703(84)90631-8 · Cited by 114
Drolet, B., Vincent, F., Rail, J., Chahine, M., Deschênes, D., Nadeau, S., Khalifa, M., Hamelin, B. A., & Turgeon, J. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38082-6 · Cited by 113
Torsades de Pointes after treatment with terfenadine and ketoconazole
ZlMMERMANN, M., Duruz, H., Guinand, O., Broccard, O., LEVY, P., Lacatîş, D., & Bloch, A. (1992) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060277 · Cited by 113
Prolonged QT interval as a predictor of mortality in diabetic nephropathy
Sawicki, P. T., DÄhne, R., Bender, R., & Berger, M. (1996) · Diabetologia · doi:10.1007/bf00400416 · Cited by 112
Dispersion of Ventricular Repolarization
Coumel, P., Maison‐Blanche, P., & Badilini, F. (1998) · Circulation · doi:10.1161/01.cir.97.25.2491 · Cited by 112
Probucol-associated tachyarrhythmic events and QT prolongation: Importance of gender
Reinoehl, J., Frankovich, D., Machado, C., Kawasaki, R., Baga, J. J., Pires, L. A., Steinman, R. T., Fromm, B. S., & Lehmann, M. H. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90095-2 · Cited by 109
Linear Relationship Between Electrical Systole, Mechanical Systole, and Heart Rate
Boudoulas, H. K., Geleris, P., Lewis, R. P., & Rittgers, S. E. (1981) · CHEST Journal · doi:10.1378/chest.80.5.613 · Cited by 109
Cardiac autonomic dysfunction in obese subjects
Rossi, M., Marti, G., Ricordi, L., Fornasari, G., Finardi, G., Fratino, P., & Bernardi, L. (1989) · Clinical Science · doi:10.1042/cs0760567 · Cited by 108
Sudden cardiac arrest in morbidly obese surgical patients unexplained after autopsy
Drenick, E. J., & Fisler, J. S. (1988) · The American Journal of Surgery · doi:10.1016/s0002-9610(88)80029-1 · Cited by 107
Honig, P. K., Wortham, D. C., Hull, R. W., Zamani, K., Smith, J. E., & Cantilena, L. R. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb03920.x · Cited by 104
Nattel, S., Ranger, S., Talajic, M. R., Lemery, R., & Roy, D. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90305-w · Cited by 104
Circadian modulation of QT rate dependence in healthy volunteers
Extramiana, F., Maison‐Blanche, P., Badilini, F., Pinoteau, J., Deseo, T., & Coumel, P. (1999) · Journal of Electrocardiology · doi:10.1016/s0022-0736(99)90019-5 · Cited by 100
Overview of electrocardiographic and cardiovascular safety data for sparfloxacin
Jaillon, P., Morganroth, J., Brumpt, I., et al. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/37.suppl_a.161 · Cited by 100
Torsade de pointes during administration of pentamidine isethionate
Wharton, J. M., Demopulos, P. A., & Goldschlager, N. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90774-1 · Cited by 97
Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans
Hartigan-Go, K. Y., Bateman, D. N., Nyberg, G., Mårtensson, E., & Thomas, S. H. L. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90150-2 · Cited by 96
Thioridazine-Induced Torsade de Pointes: Successful Therapy With Isoproterenol
Kemper, A. J. (1983) · JAMA · doi:10.1001/jama.1983.03330450061027 · Cited by 95
VORPERIAN, V. R., Zhou, Z., Mohammad, S., Hoon, T. J., Studenik, C. R., & January, C. T. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00352-x · Cited by 94
Taylor, G. J., Crampton, R. S., Gibson, R. S., Stebbins, P. T., Waldman, M. T. G., & Beller, G. (1981) · American Heart Journal · doi:10.1016/0002-8703(81)90407-5 · Cited by 92
Drug-drug interactions of new active substances: mibefradil example
Jc, K., Vožeh, S., Kondo-Oestreicher, M., et al. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050673 · Cited by 91
Puddu, P. E., & Bourassa, M. G. (1986) · Journal of Electrocardiology · doi:10.1016/s0022-0736(86)80030-9 · Cited by 91
THE NORMAL DURATION OF THE ELECTROCARDIOGRAPHIC VENTRICULAR COMPLEX
Adams, W. (1936) · Journal of Clinical Investigation · doi:10.1172/jci100784 · Cited by 90
Honig, P. K., Wortham, D. C., Zamani, K., & Cantilena, L. R. (1994) · Clinical Drug Investigation · doi:10.1007/bf03258467 · Cited by 90
Itraconazole increases plasma concentrations of quinidine*
Kaukonen, K., Olkkola, K. T., & Neuvonen, P. J. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90046-1 · Cited by 90
The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada
Walker, A. M., Szneke, P., Weatherby, L. B., DICKER, L. W., Lanza, L. L., Loughlin, J. E., Yee, C. L., & Dreyer, N. A. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00241-7 · Cited by 88
Sartori, M. P., Pratt, C. M., & Young, J. B. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90728-9 · Cited by 88
Proarrhythmia Associated With Cisapride in Children
Hill, S. L., Evangelista, J. K., Valente, A. M., Mobassaleh, M., Fulton, D. R., & Berul, C. I. (1998) · PEDIATRICS · doi:10.1542/peds.101.6.1053 · Cited by 85
Cisapride‐Induced Torsades de Pointes
Vitola, J. V., Vukanovic, J., & Roden, D. M. (1998) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1998.tb00888.x · Cited by 84
Torsades de pointes complicating treatment with terfenadine.
MacConnell, T., & Stanners, A. (1991) · BMJ · doi:10.1136/bmj.302.6790.1469-b · Cited by 84
Clinical Pharmacokinetics of Mibefradil
Welker, H. A., WILTSHIRE, H. R., & Bullingham, R. E. S. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199835060-00001 · Cited by 83
Ong, J. J. C., Sarma, J. S. M., Venkataraman, K., Levin, S. R., & Singh, B. N. (1993) · American Heart Journal · doi:10.1016/0002-8703(93)90166-7 · Cited by 83
Is QT Interval a Marker of Subclinical Atherosclerosis in Nondiabetic Subjects?
Festa, A., D’Agostino, R. B., Rautaharju, P. M., O’Leary, D. H., Rewers, M., Mykkänen, L. M., & Haffner, S. M. (1999) · Stroke · doi:10.1161/01.str.30.8.1566 · Cited by 83
Molnár, J., Weiss, J., Zhang, F., & Rosenthal, J. E. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00468-7 · Cited by 82
Antzelevitch, C. N. (1999) · Current Opinion in Cardiology · doi:10.1097/00001573-199905000-00013 · Cited by 82
Variability of the QTc interval: Impact on defining drug effect and low-frequency cardiac event
Morganroth, J., Brown, A. M., Critz, S. D., et al. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90037-d · Cited by 81
QT Interval Prolongation and Torsades de Pointes Due to Erythromycin Lactobionate
Oberg, K. C., & Bauman, J. L. (1995) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1995.tb02883.x · Cited by 78
QT-Interval prolonging drugs: Mechanisms and clinical relevance of their arrhythmogenic hazards
Zehender, M., Hohnloser, S. H., & Just, H. (1991) · Cardiovascular Drugs and Therapy · doi:10.1007/bf03029779 · Cited by 77
Hodak, S. P., Moubarak, J. B., Rodríguez, I., Gelfand, M. C., Alijani, M. R., & Tracy, C. M. (1998) · Transplantation · doi:10.1097/00007890-199808270-00021 · Cited by 77
Haloperidol-Induced Torsade De Pointes
O'Brien, J. M., Rockwood, R. P., & Suh, K. I. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.19017 · Cited by 77
QT Prolongation and Torsades de Pointes Associated with Clarithromycin
Lee, K. L., Jim, M., Tang, S. C. W., & Tai, Y. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00059-x · Cited by 76
Accidental astemizole overdose in young children
Hoppu, K., Tikanoja, T., Tapanainen, P. J., Remes, M., Kouvalainen, K., & Saarenpää, O. (1991) · The Lancet · doi:10.1016/0140-6736(91)91101-y · Cited by 75
Repeated consumption of grapefruit juice considerably increases plasma concentrations of cisapride
Kivistö, K. T., Lilja, J. J., Backman, J. T., & Neuvonen, P. J. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70007-x · Cited by 74
Effects of cisapride on QT interval in children
Khongphatthanayothin, A., Lane, J., Thomas, D., Yen, L., Chang, D. S., & Bubolz, B. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70177-5 · Cited by 73
Gonin, J. M., Kadrofske, M. M., Schmaltz, S., Bastyr, E. J., & Vinik, A. I. (1990) · Diabetes Care · doi:10.2337/diacare.13.1.68 · Cited by 71
The QT > QS2 syndrome: A new mortality risk indicator in coronary artery disease
Boudoulas, H. K., Sohn, Y. H., O’Neill, W. W., Brown, R., & Weissler, A. M. (1982) · The American Journal of Cardiology · doi:10.1016/0002-9149(82)90454-4 · Cited by 70
Life-Threatening Ventricular Arrhythmia (Torsades de Pointes) after Haloperidol Overdose
Henderson, R. A., Lane, S. M., & Henry, J. A. (1991) · Human & Experimental Toxicology · doi:10.1177/096032719101000110 · Cited by 70
Arrhythmogenic mechanisms of non‐sedating antihistamines
Yap, Y. G., & Camm, A. J. (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.0290s3174.x · Cited by 70
Self-citationTorsades de pointes in two chronic renal failure patients treated with Cisapride and Clarithromycin
Sekkarie, M. A. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90291-2 · Cited by 70
The cardiac effects of terfenadine after inhibition of its metabolism by grapefruit juice
Clifford, C., Adams, D. A., Murray, S., Taylor, G. W., Wilkins, M. R., Boobis, A. R., & Davies, D. S. (1997) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050296 · Cited by 69
Brannan, M. D., Reidenberg, P., Radwanski, E., Shneyer, L., Lin, C., Cayen, M. N., & Affrime, M. B. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90243-0 · Cited by 69
Obesity, adiposity, and lengthening of the QT interval: improvement after weight loss.
Carella, M. J., Mantz, S. L., Rovner, D. R., Willis, P. W., Gossain, V. V., Bouknight, R. R., & Ferenchick, G. S. (1996) · PubMed · Cited by 68
Azithromycin and terfenadine: Lack of drug interaction*
Harris, S. I., Hilligoss, D. M., Colangelo, P. M., Eller, M. G., & Okerholm, R. A. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90247-3 · Cited by 68
Herrmann, H. C., Kaplan, L. M., & Bierer, B. E. (1983) · The American Journal of Cardiology · doi:10.1016/s0002-9149(83)80155-6 · Cited by 66
Pharmacokinetics and pharmacodynamics of fluoroquinolones in the respiratory tract
Wise, R. A., & Honeybourne, D. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14a38.x · Cited by 66
QT Interval Length and Diabetic Autonomic Neuropathy
Ewing, D. J., & Neilson, J. M. M. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01301.x · Cited by 66
Genetics, molecular mechanisms and management of long QT syndrome
Wang, Q., Chen, Q., & Towbin, J. A. (1998) · Annals of Medicine · doi:10.3109/07853899808999385 · Cited by 65
Schoenenberger, R. A., Haefeli, W. E., Weiss, P., & Ritz, R. (1990) · BMJ · doi:10.1136/bmj.300.6736.1375 · Cited by 63
BRANDRISS, M. W., Richardson, W. S., & Barold, S. S. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.6.995 · Cited by 62
Honig, P. K., Wortham, D. C., Lazarev, A., & Cantilena, L. R. (1996) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1996.tb04210.x · Cited by 62
The cardiac effects of d- and l-disopyramide in normal subjects: a noninvasive study.
Pollick, C., Giacomini, K. M., Blaschke, T. F., Nelson, W. L., Turner-Tamiyasu, K., Briskin, V., & Popp, R. L. (1982) · Circulation · doi:10.1161/01.cir.66.2.447 · Cited by 62
Freedman, R. A., Anderson, K. P., Green, L. S., & Mason, J. W. (1987) · The American Journal of Cardiology · doi:10.1016/s0002-9149(87)80096-6 · Cited by 62
Sarma, J. S. M., Venkataraman, K., NICOD, P. H., Polikar, R., Smith, J., Schoenbaum, M. P., & Singh, B. N. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90933-r · Cited by 61
Torsades de Pointes Induced by Erythromycin
Gitler, B., Berger, L. S., & Buffa, S. D. (1994) · CHEST Journal · doi:10.1378/chest.105.2.368 · Cited by 61
QTc Interval (Cardiac Repolarization): Lengthening After Meals
Nagy, D., DeMeersman, R. E., Gallagher, D., Pietrobelli, A., Zion, A. S., Daly, D., & Heymsfield, S. B. (1997) · Obesity Research · doi:10.1002/j.1550-8528.1997.tb00573.x · Cited by 57
QT interval: A measure of drug action
Woosley, R. L., & Sale, M. E. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90039-f · Cited by 57
QT prolongation and recurrent “torsades de pointes” during erythromycin lactobionate infusion
Guélon, D., Bedock, B., Chartier, C., & Haberer, J. P. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90306-1 · Cited by 57
A Review of Erythromycin-Induced Malignant Tachyarrhythmia— Torsade de Pointes: A Case Report
Katapadi, K., Kostandy, G., Katapadi, M., Hussain, K. M. A., Schifter, D. R., & Kostandy, G. (1997) · Angiology · doi:10.1177/000331979704800909 · Cited by 56
Diseases and drugs causing prolongation of the QT interval
Laakso, M., Åberg, Å., Savola, J., Pentikäinen, P. J., & Pyörälà, K. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91107-6 · Cited by 55
Trimethoprim alters the disposition of procainamide and N-acetylprocainamide
Kosoglou, T., Rocci, M. L., & Vlasses, P. H. (1988) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1988.181 · Cited by 51
Torsades de pointes complicating treatment with terodiline.
McLeod, A. A., Thorogood, S., & Barnett, S. (1991) · BMJ · doi:10.1136/bmj.302.6790.1469-c · Cited by 49
Inhibition of L-Type Ca2+Channel Current in Rat Ventricular Myocytes by Terfenadine
Liu, S., Melchert, R. B., & Kennedy, R. H. (1997) · Circulation Research · doi:10.1161/01.res.81.2.202 · Cited by 49
Torsades de Pointes Ventricular Tachycardia Associated With Overdose of Astemizole
Rao, K. A. R. K., Adlakha, A., Verma-Ansil, B., et al. (1994) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)62252-6 · Cited by 48
Combined use of astemizole and ketoconazole resulting in torsade de pointes.
Tsai, W., Tsai, L., & Chen, J. (1997) · PubMed · Cited by 46
Hypoglycaemia leads to an increased QT interval in normal men
Eckert, B., & Agardh, C. (1998) · Clinical Physiology · doi:10.1046/j.1365-2281.1998.00138.x · Cited by 46
Hayashi, Y., Ikeda, U., Hashimoto, T., Watanabe, T., Mitsuhashi, T., & Shimada, K. (1999) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1999.tb00512.x · Cited by 46
Liberatore, M. A., & Robinson, D. S. (1984) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198406000-00006 · Cited by 44
Torsade de pointes induced by terfenadine in a patient with long QT syndrome
Koh, K. K., Rim, M. S., Yoon, J., & Kim, S. S. (1994) · Journal of Electrocardiology · doi:10.1016/s0022-0736(05)80274-2 · Cited by 41
Toivonen, L. K., Viitasalo, M. T., Pohjola‐Sintonen, S., Siikamäki, H., & Raatikka, M. (1994) · Clinical Cardiology · doi:10.1002/clc.4960170711 · Cited by 41
Pohjola‐Sintonen, S., SILTANEN, P., & Haapakoski, J. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90675-2 · Cited by 40
QT Interval and QT Dispersion Before and After Diet Therapy in Patients with Simple Obesity
Mshiu Merlyn, E., Saikawa, T., Ito, K., Hara, M., & Sakata, T. (1999) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.1999.d01-20.x · Cited by 39
Amitriptyline-induced torsade de pointes. Successful therapy with atrial pacing
Davison, E. T. (1985) · Journal of Electrocardiology · doi:10.1016/s0022-0736(85)80055-8 · Cited by 38
Assessment of QTc Prolongation for Non‐Cardiac‐Related Drugs from a Drug Development Perspective
Bonate, P. L., & Russell, T. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922007912 · Cited by 37
Cardiac arrest in a young woman with the long QT syndrome and concomitant astemizole ingestion.
Broadhurst, P., & Nathan, A. W. (1993) · Heart · doi:10.1136/hrt.70.5.469 · Cited by 36
Erythromycin-induced cardiac toxicity
Orban, Z., MacDonald, L., Peters, M. A., & Guslits, B. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80434-2 · Cited by 36
Peiris, A. N., Thakur, R. K., Sothmann, M. S., Gustafson, A. B., Hennes, M. M. I., Wilson, C. R., & Kissebah, A. H. (1991) · Southern Medical Journal · doi:10.1097/00007611-199108000-00007 · Cited by 36
Martin, D. E., Zussman, B. D., Everitt, D. E., Benincosa, L. J., Etheredge, R. C., & Jorkasky, D. K. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199712000-00003 · Cited by 35
Torsade de pointes induced by astemizole in a patient with prolongation of the QT interval
Sakemi, H., & VanNatta, B. (1993) · American Heart Journal · doi:10.1016/0002-8703(93)91021-6 · Cited by 35
Influence of itraconazole on the pharmacokinetics and electrocardiographic effects of astemizole
Lefebvre, R. A., Peer, A. V., & Woestenborghs, R. J. H. (1997) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1997.00548.x · Cited by 35
Electrocardiographic QTc interval: short-term weight loss effects
Pietrobelli, A., Rothacker, D. Q., Gallagher, D., & Heymsfield, S. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800374 · Cited by 34
Torsade de pointes in a patient receiving intravenous vasopressin
Mauro, V. F., Bingle, J. F., GINN, S. M., & Jafri, F. M. (1988) · Critical Care Medicine · doi:10.1097/00003246-198802000-00020 · Cited by 33
Clarithromycin Associated With Torsades de Pointes
Kamochi, H., Nii, T., Eguchi, K., Mori, T., Yamamoto, A., Shimoda, K., & Ibaraki, K. (1999) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.63.421 · Cited by 32
The values and limitations of the QT interval in clinical practice
Schweitzer, P. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)91013-q · Cited by 32
Murakawa, Y., Yamashita, T., Ajiki, K., Sezaki, K., & Omata, M. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199807000-00010 · Cited by 32
Mibefradil, a Pharmacologically Distinct Calcium Antagonist
Ernst, M. E., & Kelly, M. W. (1998) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1998.tb03110.x · Cited by 31
Astemizole-induced ventricular arrhythmias: an unexpected cause of convulsions
Clark, A. L., & Love, H. G. (1991) · International Journal of Cardiology · doi:10.1016/0167-5273(91)90166-m · Cited by 31
Prolonged Recurrence of Pentamidine-Induced Torsades de Pointes
Cortese, L. M., Gasser, R. A., Bjornson, D. C., Dacey, M. J., & Oster, C. N. (1992) · Annals of Pharmacotherapy · doi:10.1177/106002809202601104 · Cited by 31
Kamisako, T., Adachi, Y., Nakagawa, H., & Yamamoto, T. (1995) · Internal Medicine · doi:10.2169/internalmedicine.34.92 · Cited by 30
Functional Characteristics of QT Prediction Formulas. The Concepts of QTmax and QT Rate Sensitivity
Rautaharju, P. M., Zhou, S., Wong, S., Prineas, R. J., & Berenson, G. S. (1993) · Computers and Biomedical Research · doi:10.1006/cbmr.1993.1012 · Cited by 28
Torsades de Pointes Associated With Astemizole (Hismanal) Therapy
Goss, J. E. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410230129016 · Cited by 28
Probucol-induced QT prolongation and torsades de pointes.
松橋, 浩., Onodera, S., Kawamura, Y., Hasebe, N., Kohmura, C., Yamashita, H., & Tobise, K. (1989) · Japanese Journal of Medicine · doi:10.2169/internalmedicine1962.28.612 · Cited by 28
Carr, A. A., & Meyer, D. R. (1982) · PubMed · Cited by 28
QT Interval and primary ventricular fibrillation in acute myocardial infarction
Puddu, P. E., Jouve, R., Torresani, J., & Jouve, A. (1981) · American Heart Journal · doi:10.1016/0002-8703(81)90399-9 · Cited by 27
The dilemma of the prolonged QT interval in early drug studies
Thomas, M., Maconochie, J., & FLETCHER, E. (1996) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1996.tb00163.x · Cited by 27
Quadrel, M. A., Atkin, S. H., & Jaker, M. A. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)91047-5 · Cited by 26
Honig, P. K., Wortham, D. C., Zamani, K., Conner, D. P., Mullin, J. C., & Cantilena, L. R. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315348 · Cited by 26
Pidlich, J., Pfeffel, F., Zwiauer, K., Schneider, B., & Schmidinger, H. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800220 · Cited by 24
Sarubbi, B., Ducceschi, V., Briglia, N., Mayer, M. S., Santangelo, L., & Iacono, A. (1998) · International Journal of Cardiology · doi:10.1016/s0167-5273(98)00201-0 · Cited by 22
Drug-induced torsades de pointes in one patient with congenital long QT syndrome
HSIEH, M., Chen, S.-A., Chiang, C., TAI, C., Lee, S.-H., Wen, Z., & Chang, M.-S. (1996) · International Journal of Cardiology · doi:10.1016/0167-5273(96)02582-x · Cited by 22
Prolonged QT interval and torsade de pointes following astemizole overdose
Saviuc, P., Danel, V. C., & Dixmérias, F. (1993) · Journal of Toxicology Clinical Toxicology · doi:10.3109/15563659309000380 · Cited by 22
Molecular genetics of inherited long Qt syndromes
Geelen, J. L. M. C. (1998) · European Heart Journal · doi:10.1053/euhj.1998.0873 · Cited by 22
Atorvastatin does not Produce a Clinically Significant Effect on the Pharmacokinetics of Terfenadine
Stern, R. H., Smithers, J. A., & Olson, S. C. (1998) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1998.tb04816.x · Cited by 22
The pharmacokinetic and pharmacodynamic interaction between zileuton and terfenadine
Awni, W. M., Cavanaugh, J. H., Leese, P. T., Kasier, J., Cao, G., Locke, C. S., & Dubé, L. M. (1997) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050248 · Cited by 21
Anticholinergic Overdose Induced Torsade de Pointes Successfully Treated with Verapamil.
Liao, W.-B., Bullard, M. J., Kuo, C.-T., Hsiao, C., Chu, P., & CHIANG, C.-W. (1996) · Japanese Heart Journal · doi:10.1536/ihj.37.925 · Cited by 19
Dangers of non-sedating antihistamines
Clark, S. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62504-4 · Cited by 19
Cited by
Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties
Antzelevitch, C., Belardinelli, L., Zygmunt, A. C., Burashnikov, A., Di Diego, J. M., Fish, J. M., Cordeiro, J. M., & Thomas, G. (2004) · Circulation · doi:10.1161/01.cir.0000139333.83620.5d · Cited by 675
What Clinicians Should Know About the QT Interval
Al-Khatib, S. M., LaPointe, N. M. A., Kramer, J. M., & Califf, R. M. (2003) · JAMA · doi:10.1001/jama.289.16.2120 · Cited by 667
The impact of drug-induced QT interval prolongation on drug discovery and development
Fermini, B., & Fossa, A. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1108 · Cited by 492
Overview of Basic Mechanisms of Cardiac Arrhythmia
Antzelevitch, C., & Burashnikov, A. (2011) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2010.10.012 · Cited by 464
Sandau, K. E., Funk, M., Auerbach, A., Barsness, G. W., Blum, K., Cvach, M., Lampert, R., May, J. L., McDaniel, G. M., Perez, M. V., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000527 · Cited by 342
Metadata
- Authors
- Bednar, M. M., Harrigan, E. P., Anziano, R. J., Camm, A. J., & Ruskin, J. N.
- Venue
- Progress in Cardiovascular Diseases
- Publisher
- Elsevier BV
- Published
- 2001-04
- Volume
- 43
- Issue
- 5B
- Pages
- 1-45
- ISSN
- 0033-0620 (ISSN-L)
- OpenAlex
- W2088486084
- Cited by
- 265
- References
- 208
- FWCI
- 12.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.